SciELO - Scientific Electronic Library Online

 
vol.86 issue4  suppl.1Erosive adenomatosis of the nippleAn unusual presentation of macular amyloidosis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Anais Brasileiros de Dermatologia

Print version ISSN 0365-0596

An. Bras. Dermatol. vol.86 no.4 supl.1 Rio de Janeiro July/Aug. 2011

http://dx.doi.org/10.1590/S0365-05962011000700004 

CASE REPORT

 

The importance of patch tests in the differential diagnosis of adverse drug reactions*

 

 

Ana Rita TravassosI; David PachecoI; Joana AntunesI; Raquel SilvaII; Luís Soares AlmeidaIII; Paulo FilipeIII

IMD, Dermato-venereology intern at the University Dermatology Clinic, Santa Maria Hospital (HSM), Lisbon, Portugal
IIMD, Dermatologist, University Dermatology Clinic, Santa Maria Hospital (HSM), Lisbon, Portugal
IIIPhD, University Dermatology Clinic, Santa Maria Hospital (HSM), Lisbon, Portugal

Mailing address

 

 


ABSTRACT

Exudative erythema multiforme is an acute self-limited skin disease often associated with infections (usually viral), and also with systemic diseases and drugs. We report the case of a 39-year-old woman diagnosed with systemic lupus erythematosus, who presented at the emergency clinic with exudative erythema multiforme which started 10 days after taking amoxicillin and clavulanic acid for tonsillitis together (almost simultaneously) with the pneumococcal vaccine. Rowell's syndrome was also considered to be a possibility. Skin patch tests were carried with the standard battery of patches (GPEDC) and the active ingredients of the suspected drugs (Chemotechnique ®), with readings at D2 and D3. The tests were positive for amoxicillin 10% pet (++), ampicillin 10% pet (+ +) and penicillin G potassium 10% pet (+). We accepted the diagnosis of erythema multiforme due to amoxicillin, confirmed by patch testing.

Keywords: Amoxicillin; Erythema multiforme; Lupus erythematosus, Systemic; Patch tests


 

 

INTRODUCTION

Exudative erythema multiforme (EEM) is an acute self-limited muco-cutaneous syndrome usually associated with acute infections, including herpes simplex virus (HSV)and Mycoplasma pneumoniae and less frequently with systemic diseases (inflammatory bowel disease, systemic lupus erythematosus (SLE) / Rowell's syndrome or Behcet's disease) and drugs [non-steroid antiinflammatory drugs (NSAIDs), sulfonamides, anticonvulsants, allopurinol]. 1,2,3 The incidence of EEM associated with amoxicillin is quite rare in the literature. 3

 

CASE REPORT

We describe the case of a white 39-year-old woman with a known history of SLE for nine years who presented at the emergency clinic with erythematous papules. The papules were violet and concentric, with a pale central ring (target or iris lesion) distributed symmetrically and predominating on the extremities, clinically suggestive of EEM (Figure 1). The patient denied fever, arthralgia or other systemic symptoms.

 

 

The patient had been regularly medicated with Meticorten ® (prednisone 5mg/day) and Plaquenil ® (hydroxychloroquine) for SLE and, 10 days before the episode that led to the emergency, had been started on antibiotics (amoxicillin and clavulanic acid) for tonsillitis, at the same time as receiving the pneumococcal vaccine Pneumo 23 ®.

Diagnostic hypotheses were as follows: EEM associated with (i) prior viral infection, (ii) amoxicillin and clavulanic acid or pneumococcal vaccine or (iii) SLE (Rowell's syndrome).

The patient's history suggested a possible temporal relationship between amoxicillin/ clavulanic acid and pneumococcal vaccine. This required clarification. The patient was admitted to the Dermatology Service and treated with prednisolone (30mg/day) with rapid clinical improvement.

Histological examination of skin biopsies revealed interstitial neutrophilic dermatosis, with a positive but weak lupus band test (LBT) result. Analysis revealed: the presence of antibodies (Ab), anti-Epstein-Barr virus (EBV), positive IgG and IgM, positive antinuclear antibody (ANA) (up to 1/640), homogeneous nuclear pattern, anti-double-stranded DNA (ds-DNA-Ab) and positive anti-Ro antibodies.

After reducing the dose of prednisolone to 5mg/day (dose previously established to control the SLE), the patient was referred for contact patch tests. These were performed 8 weeks later with the standard battery (GPEDC) and the suspect active drug ingredients in vaseline (Chemotechnique ®). Readings taken at 48 and 72 hours revealed hypersensitivity to amoxicillin 10% vas (++), ampicillin 10% vas (+ +) and penicillin G potassium 10% vas (+) (Figure 2).

 

 

DISCUSSION

EEM, the Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) were considered from a classical nosographic perspective to be related dermatoses, given that they possessed common reactive and etiological characteristics (infections, drugs and systemic diseases) 4.5. Agreement exists at present on the concept of separating the EEM spectrum from the SJS/TEN spectrum. 1

Despite the infections (especially HSV) being considered as the main cause of EEM, as opposed to SJS and TEN, whose etiology is largely due to drugs, their association with drug reactions is described in the literature (in particular: sulfonamides, phenytoin, NSAIDs and allopurinol). 1,4,3,5

Allergic reactions to drugs are traditionally classified according to Coombs and Gell as the following: immediate hypersensitivity reactions (Type I), cytotoxic reactions (Type II), immune-mediated (Type III) reactions and delayed hypersensitivity reactions (Type IV-mediated by T cells). 6.7 According to the latest knowledge about the function of T cells, Type IV reactions were subclassified as IVa-IVd, with the reactions associated with type IVc: maculopapular, bullous and neutrophilic skin reactions (with a prevalence of SJS and TEN), in which the role of cytotoxic T cells predominates through cytotoxicity mediated by CD8+ T cells, with the destruction of keratinocytes. 7

In some cases, both agents (drugs and infection) can be identified as potentially precipitating EEM. 3 Viral infections have been associated with increased risk of allergic reactions and, although the exact mechanism is not yet fully known, a breakdown of tolerance or an enhanced immune reaction to drugs after a viral infection have been suggested. Two mechanisms have been proposed:(i) antigenic expres sion changes occurring in the drug or its metabolites, probably associated with changes in the expression of enzymes that metabolize the respective drugs, or (ii) changes in the regulation of immune response. 3

With regard to the diagnosis of Rowell's syndrome in this particular case, the currently-accepted criteria as defined by Zeitoun et al. are not fulfilled, despite the existence of a strong etiological link to the ingestion of drugs (amoxicillin). 8,9,10 RS is defined by the presence of three major criteria: (i) recognition of SLE, discoid lupus or sub-acute lupus; (ii) erythema multiforme lesions, with or without mucosal involvement; and (iii) positive ANA in speckled pattern and at least one minor criteria: (i) perniosis; (ii) anti-Ro or anti-La positive antibodies; and (iii) a positive rheumatoid factor (RF). 8,9,10

We believe that the most likely cause for the EEM was amoxicillin. The epicutaneous contact tests proved hypersensitivity to ampicillin vas 10% (+ +) and amoxicillin 10% vas (+ +) and (less intensely) to penicillin G potassium vas 10% (+). For these reasons we recommended ruling out treatment with any antibiotic in this group of drugs.

It is worth noting the presence of some possible EEM triggers: viral infection (EBV), drugs (amoxicillin) and systemic disease (SLE). Note also the importance of using contact patch tests for the clinical imputation of amoxicillin and the clinical characterization of cross-reactions, both of which provided the patient with a more accurate list of medicines to be avoided.

 

REFERENCES

1. Criado PR, Criado RFJ, Vasconcellos C, Ramos RO, Gonçalves AC. Reações cutâneas graves adversas a drogas - aspectos relevantes ao diagnóstico e ao tratamento - Parte I - anafilaxia e reações anafilactóides, eritrodermias e espectro clínico da síndrome de Stevens-Johnson & necrólise epidérmica tóxica (Doença de Lyell). An. Bras. Dermatol. 2004;79:471-88.         [ Links ]

2. French LE, Prins C. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Bolognia J, Jorizzo J, Rapini R, editors. Dermatology. 2nd ed. New York: Elsevier; 2008. p.287-99.         [ Links ]

3. González-Delgado P, Blanes M, Soriano V, Montoro D, Loeda C, Niveiro E. Erythema multiforme to amoxicillin with concurrent infection by Epstein-Barr virus. Allergol Immunopathol (Madr). 2006;34:76-78.         [ Links ]

4. Rodrigo EG, Gomes MM, Mayer-Silva A, Filipe PL. Eritema Multiforme. In: Rodrigo FG. Dermatologia: Ficheiro clínico e terapêutico. 1 ed. Lisboa: Fundação Calouste Gulbenkian; 2010. p.335-338.         [ Links ]

5. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population - based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990;126:43-7.         [ Links ]

6. Bruynzeel DP, Gonçalo M. Patch testing in adverse drug reactions. In: Frosch PJ, Menné T, Lepoittevin JP, editors. Textbook of Contact Dermatitis. 4th ed. Berlin: Springer; 2006. p.401-412.         [ Links ]

7. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions- new concepts. Clin Exp Allergy. 2007;37:989-99.         [ Links ]

8. Zeitouni NC, Funaro D, Cloutier RA, Gagné E, Claveau J. Redefining Rowell's syndrome. Br J Dermatol. 2000;142:343-6.         [ Links ]

9. Kacalak-Rzepka A, Kiedrowicz M, Bielecka-Grzela S, Ratajczak-Stefanska V, Maleszka R, Mikulska D. Rowell's syndrome in the course of treatment with sodi um valproate: a case report and review of the literature data. Clin Exp Dermatol. 2009;34:702-4.         [ Links ]

10. Duarte AF, Mota A, Pereira M, Baudrier T, Azevedo F. Rowell syndrome- case report and review of the literature. Dermatol Online J. 2008;14:15.         [ Links ]

 

 

Mailing address:
Ana Rita Travassos
Clínica Universitária de Dermatologia - Hospital de Santa Maria
Avenida Professor Egas Moniz
1649 028 Lisboa, Portugal
Tel./Fax: 00351-9-6234-1475; 00351-2-1795-4447
E-mail: ritatravassos@gmail.com

Received on 11.02.2011.
Approved by the Advisory Board and accepted for publication on 24.03.2011.
Conflict of interest: None
Financial funding: None

 

 

* Study undertaken at: University Dermatology Clinic, Santa Maria Hospital (HSM), Lisbon, Portugal.